• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establidhment of highly-sensitive TERT mutation assay in glioma

Research Project

Project/Area Number 18K09003
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 56010:Neurosurgery-related
Research InstitutionSaitama Medical University

Principal Investigator

ADACHI JUNICHI  埼玉医科大学, 医学部, 准教授 (70291143)

Co-Investigator(Kenkyū-buntansha) 西川 亮  埼玉医科大学, 医学部, 教授 (90237678)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2020: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
KeywordsGlioma / TERT / ddPCR / glioma / droplet digital PCR / digital PCR / 遺伝子変異 / プロモーター / HRM / mutation
Outline of Final Research Achievements

It is important to accurately detect TERT promoter mutations in glioma. Sanger DNA sequencing is the currently standard method for analyzing TERT mutations. In this report, we described a novel droplet digital PCR (ddPCR) assay to evaluate TERT hot spot mutations in fresh frozen and formalin-fixed paraffin-embedded (FFPE) specimens of glioma and verified the difference in results from the Sanger DNA sequencing results. We obtained the mutant allele fraction for TERT mutations of in a single ddPCR run in all cases, including the microdissected FFPE sections. On the contrary, up to twice the DNA sequences were required from fresh frozen tissue to obtain the results, consistent with ddPCR assay. When FFPE specimens were used, more time was required to evaluate TERT mutations through DNA sequencing. DdPCR is an effective and sensitive assay compared to the conventional standard Sanger DNA sequencing.

Academic Significance and Societal Importance of the Research Achievements

ddPCR法はサンプル内にPCR増幅される遺伝子があれば必ず増幅検出されるため、0.01%の変異DNAでも検出が可能な高感度な遺伝子変異検出法であり再現性も高い。特に変異のホットスポットが判明しているTERT遺伝子変異の解析に対しては極めて有用な方法である。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (11 results)

All 2021 2020 2019 2018

All Journal Article (3 results) (of which Peer Reviewed: 3 results) Presentation (8 results) (of which Int'l Joint Research: 3 results)

  • [Journal Article] Droplet digital PCR assay for detection of TERT promoter mutations in glioma patients2021

    • Author(s)
      Adachi J, Shirahata M, Suzuki T, Mishima K, Uchida E, Sasaki A, Nishikawa R
    • Journal Title

      Brain Tumor Pathology

      Volume: -

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas2019

    • Author(s)
      Miyake Y, AdachiJ, Suzuki T, Mishima K, Araki R, Mizuno R, Nishikawa R
    • Journal Title

      Journal of Neuro-Oncology

      Volume: 141 Issue: 1 Pages: 131-138

    • DOI

      10.1007/s11060-018-03016-8

    • Related Report
      2019 Research-status Report 2018 Research-status Report
    • Peer Reviewed
  • [Journal Article] Novel, improved grading system(s) for IDH-mutant astrocytic gliomas2018

    • Author(s)
      Shirahata M, Adachi J, et al
    • Journal Title

      Acta Neuropathologica

      Volume: 136 Issue: 1 Pages: 153-166

    • DOI

      10.1007/s00401-018-1849-4

    • Related Report
      2018 Research-status Report
    • Peer Reviewed
  • [Presentation] グリオーマにおける高感度TERT遺伝子変異検出法の確立2020

    • Author(s)
      安達淳一、白畑充章、鈴木智成、三島一彦、藤巻高光、西川 亮
    • Organizer
      日本脳神経外科学会 第79回学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] グリオーマにおける Droplet Digital PCR 法を用いた高感度TERT遺伝子変異解析2020

    • Author(s)
      安達淳一、白畑充章、鈴木智成、三島一彦、藤巻高光、西川 亮
    • Organizer
      第38回 日本脳腫瘍学会 学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 下垂体腺腫の腫瘍増大に関わるTERT遺伝子プロモーターメチル化の意義2019

    • Author(s)
      三宅勇平, 安達淳一, 鈴木智成, 三島一彦, 荒木隆一郎, 佐々木惇, 西川 亮
    • Organizer
      第37回 日本脳腫瘍病理学会 学術総会
    • Related Report
      2019 Research-status Report
  • [Presentation] TERTTERT promoter methylation is significantly associated with TERTupregulation and tumor progression in pituitary adenomas2019

    • Author(s)
      Adachi J, Miyake Y, Suzuki T, Mishima K, Araki R, Nishikawa R
    • Organizer
      14th European Association of Neuro-Oncology annual meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] MGMT methylation cutoff value in quantitative analysis related to prognosis of newly diagnosed glioblastoma2019

    • Author(s)
      Adachi J, Shirahata M, Suzuki T, Mishima K, Nishikawa R
    • Organizer
      24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] 高MGMTプロモーターメチル化膠芽腫の再発後の経過と予後の解析2019

    • Author(s)
      安達淳一、白畑充章、鈴木智成、三島一彦、藤巻高光、西川 亮
    • Organizer
      第37回 日本脳腫瘍学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 膠芽腫の予後を規定する MGMTメチル化定量解析 法におけるメチル化カット オフ値の設定2018

    • Author(s)
      安達淳一, 白畑充章, 鈴木智成, 三島 一彦, 藤巻高光, 西川 亮
    • Organizer
      日本脳神経外科学会  第77回学術総会
    • Related Report
      2018 Research-status Report
  • [Presentation] Liquid biopsy using cell free DNA from the cerebrospinal fluid (CSF) in glioma2018

    • Author(s)
      Adachi J, Suzuki T, Mishima K, Nishikawa R
    • Organizer
      23rd Annual Meeting of the Society for Neuro-Oncology
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi